PATENT CLAIM ANALYSIS

Application Number: 16235652
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-07
Patent Classification: ["540", "520000"]

Abstract:
Disclosed herein, in various embodiments, are compounds having dual activity as PARP1 and CDK inhibitors, and pharmaceutical compositions comprising the same. In some embodiments, the present disclosure provides for methods of treating diseases or conditions in a subject in need thereof, comprising administering one or more compounds disclosed herein. In some embodiment, the disease is cancer, including breast cancer.

Claim (Index 19):
The compound of  claim 18 , wherein the A ring is a C 5-8  aryl.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 98.0
- Lexical Diversity: 1.4375
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16230412', '14977011', '14413745', '13217132', '13079763']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7194376720048423
- 35 USC 102 Novelty (BERT): 0.5278917158217156
- Combined Prediction Score: 0.7002830763865296
- Mean Citation Score: 306.95854
- Max Citation Score: 319.27917
- Similarity Product: 200.2783502239108

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test